Polaris Group
Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications, as well as provides healthcare consulting, staffing, and MDS solutions. The company was incorporated in 20… Read more
Market Cap & Net Worth: Polaris Group (6550)
Polaris Group (TW:6550) has a market capitalization of $619.85 Million (NT$20.51 Billion) as of March 18, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #13650 globally and #445 in its home market, demonstrating a -17.62% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Polaris Group's stock price NT$23.85 by its total outstanding shares 859892688 (859.89 Million).
Polaris Group Market Cap History: 2016 to 2026
Polaris Group's market capitalization history from 2016 to 2026. Data shows change from $1.02 Billion to $619.85 Million (-12.90% CAGR).
Polaris Group Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Polaris Group's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
11.09x
Polaris Group's market cap is 11.09 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $423.63 Million | $9.41 Million | -$660.22 Million | 45.02x | N/A |
| 2021 | $1.90 Billion | $15.04 Million | -$740.49 Million | 126.31x | N/A |
| 2022 | $2.31 Billion | $6.44 Million | -$1.15 Billion | 358.02x | N/A |
| 2023 | $1.96 Billion | $7.48 Million | -$1.58 Billion | 262.64x | N/A |
| 2024 | $1.19 Billion | $107.00 Million | -$2.50 Billion | 11.09x | N/A |
Competitor Companies of 6550 by Market Capitalization
Companies near Polaris Group in the global market cap rankings as of March 18, 2026.
Key companies related to Polaris Group by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Polaris Group Historical Marketcap From 2016 to 2026
Between 2016 and today, Polaris Group's market cap moved from $1.02 Billion to $ 619.85 Million, with a yearly change of -12.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$619.85 Million | -23.31% |
| 2025 | NT$808.27 Million | -31.87% |
| 2024 | NT$1.19 Billion | -39.62% |
| 2023 | NT$1.96 Billion | -14.77% |
| 2022 | NT$2.31 Billion | +21.34% |
| 2021 | NT$1.90 Billion | +348.47% |
| 2020 | NT$423.63 Million | -13.30% |
| 2019 | NT$488.60 Million | -33.58% |
| 2018 | NT$735.62 Million | -49.24% |
| 2017 | NT$1.45 Billion | +41.80% |
| 2016 | NT$1.02 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Polaris Group was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $619.85 Million USD |
| MoneyControl | $619.85 Million USD |
| MarketWatch | $619.85 Million USD |
| marketcap.company | $619.85 Million USD |
| Reuters | $619.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.